Ann Arbor, Mich. – Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas, a particularly debilitating complication of Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data. The resulting paper, “Early tumour necrosis factor antagonist treatment prevents perianal...
research News
Ann Arbor, Michigan – People with higher levels of metals found in their blood and urine may be more likely to be diagnosed with — and die from — amyotrophic lateral sclerosis, or ALS, a University of Michigan-led study suggests. Researchers have known that ALS, a rare but fatal neurodegenerative...
Milan, Italy – A study coordinated by Stefania Corti and Dario Ronchi of the Dino Ferrari Center at the University of Milan and the Policlinico Hospital of Milan has identified and characterized rare genetic variants in patients with spinal muscular atrophy (SMA), a serious, rare neuromuscular disease that damages motor...
Minneapolis, Minn. – Published in the Journal of Infectious Diseases, this research led by the University of Minnesota Medical School offers a new avenue of hope in the fight against chronic human immunodeficiency virus (HIV) infection. The researchers explored the use of Natural Killer (NK) cells aiming to restore their...
MINNEAPOLIS / ST. PAUL, Minn. — Researchers at the University of Minnesota, have developed a new visual diagnostic technique that can be used to advance early detection for neurodegenerative diseases like Parkinson’s disease and similar diseases that affect animals, including Chronic Wasting Disease in deer. The research is published in npj...
MINNEAPOLIS/ST. PAUL — In a major scientific breakthrough, newly published research from an international consortium led by the University of Minnesota’s Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment. Published today in JAMA Network Open, the findings indicate that ovarian cancer patients with high levels...
Columbia, Missouri – New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes. More than 30 million Americans live with Type 2 diabetes. One common feature of diabetes is the hardening and...
Münster, Germany – In a transformative study published in the Journal Science Translational Medicine, an international team of researchers, led by the University of Münster and Department of Neurology at the University Hospital of Münster, Germany, in collaboration with the German Competence Network Multiple Sclerosis (KKNMS), has made a significant...
CHAPEL HILL, N.C. – UNC School of Medicine researcher Sarah Cohen, PhD, and Ian Windham, a former PhD student from the Cohen lab, have made a new discovery about apolipoprotein E (APOE) – the biggest genetic risk factor for late-onset Alzheimer’s disease. Older people who inherited a genetic variant called...
NORMAN, Oklahoma – In the past year, three researchers at the University of Oklahoma College of Medicine at OU Health Sciences have earned more than $5 million in grant money to study causes and potential treatments for necrotizing enterocolitis, a deadly intestinal disease that primarily affects infants born prematurely. Because...